Sign in
Explore the registryTrack Selpercatinib's trials

LIBRETTO-431

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

SelpercatinibOngoingActive not recruitingPhase 3Open NCT04194944 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…